BPC-157
The most-discussed healing peptide, built on a stomach-protein fragment.
Overview
A 15-amino-acid peptide derived from a protein found in gastric juice. In rodents it speeds healing of tendon, muscle, ligament, gut and nerve injuries. Human data is almost nonexistent, so nearly everything you read is extrapolated from animal work and user reports.
How it works
Appears to up-regulate growth-factor receptors (VEGFR2, growth hormone receptor), promote new blood vessel formation (angiogenesis), and modulate nitric-oxide signaling. Exact human pharmacology is not established.
Evidence
2/5
Dozens of rodent studies; only tiny human pilot data (e.g. knee pain retrospective, IV safety pilot).
Half-life
Short (hours); effects thought to be local + signaling driven
Known as
Body Protection Compound-157, Bepecin, PL 14736
Compound facts
- Type
- Synthetic pentadecapeptide
- CAS Number
- 137525-51-0
- Molecular Weight
- 1419.5 g/mol
- Amino Acids
- 15
- Sequence
- GEPPPGKPADDAGLV
- Formula
- C62H98N16O22
Reported benefits
Tendon / ligament healing
Accelerated healing and tendon-to-bone repair in rat models.
Gut lining protection
Reduced ulcer and colitis damage in animals; origin of the name 'body protection'.
Joint & muscle recovery
Users commonly report less joint pain and faster return to training.
Angiogenesis
Promotes blood-vessel growth around injury in lab models.
“Anecdotal” means reported by users, not shown in controlled trials.
Community-reported regimens
Not recommendations. These are commonly cited ranges, shown so you can see what real-world use looks like.
| Plan | Dose | Frequency | Duration | Route |
|---|---|---|---|---|
| Standard Most commonly cited starting point. | 250 mcg | 1–2× daily | 4–6 weeks | Subcutaneous, near injury site |
| Higher Upper end of community range; take 2–4 weeks off after. | 500 mcg | 1–2× daily | 6–8 weeks | Subcutaneous |
| Cautious start | 200 mcg | Once daily | 2 weeks, then reassess | Subcutaneous |
Reconstitution calculator
Set up for BPC-157. Switch peptide or vial size any time.
1Mix
Add 2 mL water for 5 mg/mL
2Draw
Draw to 5 units = 0.05 mL = 250 mcg
Drag the plunger to set your dose.
3Inject
Next site
Right belly, upper
Tap a site after you inject to keep a rotation.
Some inject near the injury; the map shows standard sites. Pinch the skin, stay 2 in. from the navel, then into a sharps bin.
- Doses per vial
- 40
- Vial lasts
- 40 days
- Good once mixed
- ~28 days
- Syringe
- 30-unit, 0.3 mL
The vial outlasts its ~28-day shelf life once mixed. A smaller vial wastes less.
Math only: concentration (mg/mL) = vial mg ÷ mL of water; units = dose (mg) ÷ concentration × 100. Always double-check against your own vial label and a clinician. This tool does not recommend a dose.
Reconstitution
Diluent: Bacteriostatic water (0.9% benzyl alcohol) — allows multiple draws from one vial.
- Wipe both vial tops with an alcohol swab and let dry.
- Draw the diluent, then inject it slowly down the inside wall of the vial — never straight onto the powder.
- Swirl gently or let it sit; do not shake. Foam can damage peptides.
- Solution should be clear. Cloudy, stringy or discolored = discard.
- Common mix: 5 mg + 2 mL = 2.5 mg/mL (250 mcg = 10 units).
Storage
Powder
Freezer / fridge
Keep sealed vial in the freezer (−20 °C) for long-term storage; fridge (2–8 °C) is fine for a few weeks. Keep dry and out of light.
After mixing
~28 days
Refrigerate at 2–8 °C. Never freeze after mixing. Keep upright, capped, and out of light.
Travel
Keep cool
Short trips at room temperature are generally fine for powder; keep mixed vials cold.
- Stable-form arginine salt (BPC-157 'Arg') is marketed for oral use but is separate from this injectable.
Side effects & cautions
Reported side effects
- Injection-site redness or itch
- Mild nausea or dizziness
- Fatigue or flushing
- Unknown long-term effects
Cautions
- Theoretical concern: promotes angiogenesis, which could matter if you have a cancer history.
- No data in pregnancy or breastfeeding.
- Banned by WADA — tested athletes should not use it.
FDA & international status
Not FDA-approved for any use
Not an approved drug. FDA had listed it in compounding Category 2 (safety concerns) until April 2026, when its nomination was withdrawn. On July 23, 2026 FDA's compounding advisory committee voted 8–6 to recommend adding it to the 503A bulks list; a recommendation is not approval. Sold online as a 'research chemical'. Check the FDA 503A categories page for the current status.
Regulations change often — verify with the FDA, EMA, MHRA, Health Canada, TGA and WADA before acting.
Often paired with
TB-500The popular 'Wolverine' pairing — BPC-157 for local repair, TB-500 for systemic recovery.
Where to buy
BPC-157 vials
| Size | Price | Per mg | Stock | Latest COA |
|---|---|---|---|---|
| 10 mg | $39.99 | $4.00 | In stock | 99.61% pure, lot BP0002 ILS Labs, tested 2026-07-30 |
BPC-157 nasal spray (ready-made)
View ↗| Size | Price | Per mg | Stock | Latest COA |
|---|---|---|---|---|
| 15 mg | $59.99 | $4.00 | Out of stock | 99.67% pure, lot SBPC0001 ILS Labs, tested 2026-08-20 |
Amino Club list prices as of 2026-10-07, before promo codes. Multi-buy: 2+ units 5% off, 3+ units 7.5% off, 10+ units 40% off. Prices change; confirm on the product page. Mixing? Their bacteriostatic water is Amino H2O from $19.99.
BPC-157 at Amino Club
Check sizes, current price and the certificate of analysis (COA) on the product page. Sold for in-vitro research only.
Get BPC-157 alerts
An email when its price drops, a sale starts, or its FDA or WADA status changes.
Affiliate link: we may earn a commission at no cost to you. Disclosure
- Look for a batch-specific COA with HPLC purity (≥98%) and mass-spec identity.
- Typical vial sizes: 5, 10 mg.
FAQ
Does it have to be injected near the injury?
Many users inject subcutaneously close to the site; others inject in the abdomen. There is no human trial proving one is better.
Is oral BPC-157 as good as injectable?
Animal gut studies used oral dosing, but systemic effects in humans are unproven for either route.
How long until I'd notice something?
Users typically report 1–3 weeks. Because evidence is anecdotal, placebo effect can't be ruled out.